Stay updated with breaking news from Nasdaq Blph. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com started coverage on shares of Bellerophon Therapeutics (NASDAQ:BLPH – Get Rating) in a research note issued to investors on Thursday. The brokerage set a “sell” rating on the biotechnology company’s stock. BLPH has been the subject of a number of other reports. Zacks Investment Research cut Bellerophon Therapeutics from a “buy” rating to a […]
StockNews.com assumed coverage on shares of Bellerophon Therapeutics (NASDAQ:BLPH – Get Rating) in a research note released on Monday. The firm issued a sell rating on the biotechnology company’s stock. A number of other analysts also recently commented on BLPH. Zacks Investment Research downgraded Bellerophon Therapeutics from a buy rating to a hold rating in […]
StockNews.com assumed coverage on shares of Bellerophon Therapeutics (NASDAQ:BLPH – Get Rating) in a research report released on Sunday morning. The brokerage issued a sell rating on the biotechnology company’s stock. Separately, Zacks Investment Research downgraded shares of Bellerophon Therapeutics from a buy rating to a hold rating in a research note on Wednesday, January […]
Equities research analysts forecast that Bellerophon Therapeutics, Inc. (NASDAQ:BLPH – Get Rating) will report earnings of ($0.60) per share for the current fiscal quarter, according to Zacks Investment Research. Zero analysts have issued estimates for Bellerophon Therapeutics’ earnings. Bellerophon Therapeutics reported earnings per share of ($0.84) during the same quarter last year, which would indicate […]